• Cabazitaxel (XRP6258): Technical Guidance for Taxane-Resista

  2026-07-13

  Cabazitaxel (XRP6258) is designed for research targeting taxane-resistant tumor models, particularly those expressing P-glycoprotein. It is unsuitable for water-based systems or long-term storage in solution, and is best used in DMSO- or ethanol-based workflows where careful handling preserves compound stability.

• Veratridine: Voltage-Gated Sodium Channel Opener in Research

  2026-07-12

  Veratridine is a potent voltage-gated sodium channel opener widely used to study sodium channel dynamics, excitotoxicity, and seizure mechanisms. APExBIO’s Veratridine (CAS 71-62-5) enables reproducible, quantitative assays for neuroscience and cancer biology research. Its mechanism and protocol parameters are well-documented for high-fidelity experimental workflows.

• Perphenazine: Dopamine D2 Receptor Antagonist in Research Wo

  2026-07-10

  Perphenazine’s unique multi-receptor profile enables robust experimental models in both neuropharmacology and host-directed antibacterial research. Explore detailed stepwise protocols, troubleshooting solutions, and comparative insights for optimizing mitochondria-mediated cell death and immune modulation assays with APExBIO’s rigorously characterized compound.

• 2',7'-Dichlorofluorescein Diacetate Probe in ROS Assays

  2026-07-09

  2',7'-Dichlorofluorescein diacetate transforms intracellular ROS measurement by offering robust, real-time quantification in advanced cancer and toxicology research. This article details experimental workflows, troubleshooting tips, and key protocol parameters to maximize assay reliability—highlighting breakthrough applications from recent nanocarrier research in pancreatic cancer.

• KNUCKLES Integrates Hormonal Signals for Floral Meristem Ter

  2026-07-09

  This study uncovers how the KNUCKLES (KNU) transcription factor directly coordinates auxin and cytokinin dynamics to ensure proper termination of the floral meristem (FM) in Arabidopsis. By mapping a molecular network that links hormone distribution to transcriptional repression, the research advances our understanding of developmental timing and organogenesis in plants.

• HyperScribe All in One mRNA Synthesis Kit: Applied Workflows

  2026-07-08

  The HyperScribe All in One mRNA Synthesis Kit streamlines ARCA-capped, polyadenylated mRNA production for cutting-edge vaccine and RNA research. Its robust, user-friendly workflow enables precise control from template to translation-ready mRNA, powering innovations from neoantigen vaccine development to advanced functional genomics.

• JHU-083: Precision Glutaminase Inhibition for Neuroinflammat

  2026-07-08

  Discover how JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, enables advanced, selective modulation of glutaminase pathways in neuroinflammatory research. This article provides unique insights into mechanistic workflows, practical assay design, and translational limitations.

• Geneticin (G-418 Sulfate): Advanced Selective Pressure and T

  2026-07-07

  Explore the multifaceted roles of G418 Sulfate (Geneticin), including its unique protein synthesis inhibition, advanced applications in genetic engineering, and antiviral research. This article provides a deeper mechanistic and translational perspective not found in existing guides.

• Artesunate: Mechanistic Mastery and New Frontiers in Cancer

  2026-07-07

  This thought-leadership article explores Artesunate—a high-purity artemisinin derivative from APExBIO—as a mechanistically distinct anticancer compound. It integrates the latest mechanistic insights, translational guidance, and protocol best practices, referencing cutting-edge scholarship and in vitro evaluation frameworks. The piece moves beyond standard product pages by synthesizing evidence on AKT/mTOR pathway inhibition, ferroptosis induction, and the evolving standards for in vitro cancer drug evaluation.

• Oral CXCR4 Antagonism in WHIM Syndrome: Phase 3 Trial Insigh

  2026-07-06

  A recent placebo-controlled phase 3 trial demonstrates that mavorixafor, a potent oral CXCR4 antagonist, significantly improves neutrophil and lymphocyte counts and reduces infection rates in WHIM syndrome—a rare immunodeficiency. The study highlights the clinical potential of targeting CXCR4 signaling with an orally bioavailable agent, addressing longstanding limitations of prior therapies.

• MALAT1 Modulates PCT in Sepsis via miR-125b/STAT3: Mechanist

  2026-07-06

  This study uncovers a regulatory axis in sepsis where the long noncoding RNA MALAT1 upregulates procalcitonin (PCT) expression by sponging miR-125b and activating STAT3, highlighting a new layer of post-transcriptional control. These findings clarify the molecular mechanisms driving PCT elevation in sepsis and suggest novel avenues for diagnostic and therapeutic strategies.

• GDC-0941: Advanced Insights into PI3K Inhibition and Cancer

  2026-07-05

  Explore the multifaceted role of GDC-0941 as a PI3K inhibitor, with new insights into targeting cancer stem cell resistance and the PI3K/Akt pathway. This article uniquely bridges molecular mechanism, assay optimization, and the latest translational research.

• Applied Workflows with BPN-19186 in sEH–Nrf2 Pathway Researc

  2026-07-04

  BPN-19186 ((S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea) offers researchers a high-purity, robustly soluble tool for precise modulation of the sEH–Nrf2 axis in osteoclastogenesis and redox signaling assays. This guide distills recent breakthrough findings into reproducible experimental steps, troubleshooting strategies, and workflow enhancements for biochemical, cancer, and neuroscience research applications.

• Enhancing Apoptosis in Pancreatic Cancer via Caspase-8/c-FLI

  2026-07-03

  This study demonstrates that pharmacological targeting of the caspase-8/c-FLIPL heterodimer, in combination with death ligands, gemcitabine, and the MCL1 inhibitor S63845, significantly enhances apoptotic cell death in pancreatic cancer cells. The findings highlight the potential of combinatorial strategies to overcome apoptosis resistance and improve therapeutic specificity in challenging malignancies.

• SB743921 in Cancer Research: Precision Tools for Mitotic Arr

  2026-07-03

  Explore how SB743921, a potent kinesin spindle protein inhibitor, redefines mitotic arrest strategies in cancer research. This article delivers advanced scientific insights, unique protocol parameters, and practical guidance that goes beyond existing SB743921 resources.

457 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page